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Abstract 
Background: Persistent hyperlactatemia has been considered as a signal of tissue hypoperfusion in septic shock 
patients, but multiple non‑hypoperfusion‑related pathogenic mechanisms could be involved. Therefore, pursuing 
lactate normalization may lead to the risk of fluid overload. Peripheral perfusion, assessed by the capillary refill time 
(CRT), could be an effective alternative resuscitation target as recently demonstrated by the ANDROMEDA‑SHOCK 
trial. We designed the present randomized controlled trial to address the impact of a CRT‑targeted (CRT‑T) vs. a 
lactate‑targeted (LAC‑T) fluid resuscitation strategy on fluid balances within 24 h of septic shock diagnosis. In addi‑
tion, we compared the effects of both strategies on organ dysfunction, regional and microcirculatory flow, and tissue 
hypoxia surrogates.
Results: Forty‑two fluid‑responsive septic shock patients were randomized into CRT‑T or LAC‑T groups. Fluids were 
administered until target achievement during the 6 h intervention period, or until safety criteria were met. CRT‑T 
was aimed at CRT normalization (≤ 3 s), whereas in LAC‑T the goal was lactate normalization (≤ 2 mmol/L) or a 20% 
decrease every 2 h. Multimodal perfusion monitoring included sublingual microcirculatory assessment; plasma‑disap‑
pearance rate of indocyanine green; muscle oxygen saturation; central venous‑arterial  pCO2 gradient/ arterial‑venous 
 O2 content difference ratio; and lactate/pyruvate ratio. There was no difference between CRT‑T vs. LAC‑T in 6 h‑fluid 
boluses (875 [375–2625] vs. 1500 [1000–2000], p = 0.3), or balances (982[249–2833] vs. 15,800 [740–6587, p = 0.2]). 
CRT‑T was associated with a higher achievement of the predefined perfusion target (62 vs. 24, p = 0.03). No significant 
differences in perfusion‑related variables or hypoxia surrogates were observed.
Conclusions: CRT‑targeted fluid resuscitation was not superior to a lactate‑targeted one on fluid administration or 
balances. However, it was associated with comparable effects on regional and microcirculatory flow parameters and 
hypoxia surrogates, and a faster achievement of the predefined resuscitation target. Our data suggest that stopping 
fluids in patients with CRT ≤ 3 s appears as safe in terms of tissue perfusion.
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Background
Persistent hyperlactatemia has been traditionally con-
sidered as a signal of tissue hypoperfusion or hypoxia in 
septic shock patients [1]. Therefore, lactate normaliza-
tion is recommended as a resuscitation target by recent 
guidelines [2]. However, hyperlactatemia is a non-specific 
marker of hypoperfusion, since other pathogenic mecha-
nisms such as sustained hyperadrenergia and impaired 
hepatic clearance may contribute to increased serum 
lactate levels [1, 3, 4]. This may have relevant clinical 
implications, since if non-hypoperfusion-related sources 
predominate, increased serum lactate levels This may 
have relevant clinical implications, since if non-hypoper-
fusion-related sources predominate, pursuing lactate as 
a target may lead to fluid overload, potentially increasing 
mortality or morbidity [5–7]. In addition, kinetics of lac-
tate recovery is relatively slow, which makes it a subopti-
mal target for fluid resuscitation [4, 8].
Peripheral perfusion appears as a promising alterna-
tive target [9, 10]. The excellent prognosis associated with 
capillary refill time (CRT) normalization [11], the rapid-
response time to fluid loading [8], plus its simplicity and 
availability in resource-limited settings, constitute a solid 
background to promote studies evaluating its usefulness 
to guide fluid resuscitation. The ANDROMEDA-SHOCK 
trial was implemented within 4  h of septic shock diag-
nosis and compared a CRT-vs. a lactate-targeted resus-
citation strategy [12–14]. The CRT group exhibited a 
non-significant lower mortality (34.9 vs. 43.4%, p = 0.06), 
required less fluid resuscitation during the intervention 
period, and presented less organ dysfunction at 72 h. A 
posterior Bayesian analysis showed a very high probabil-
ity that CRT-targeted resuscitation may result in lower 
mortality and faster resolution of organ dysfunction 
compared to a lactate-targeted one [15]. ANDROMEDA-
SHOCK results should be confirmed by future major tri-
als, but in the meantime, many non-resolved issues could 
be addressed by smaller randomized controlled trials 
including the effect of both strategies on organ perfusion.
We designed the present trial to address the impact 
of a CRT-targeted vs. lactate-targeted fluid resuscita-
tion strategy started within 24 h after septic shock diag-
nosis on fluid administration and balances. In addition, 
we aimed at comparing the effects of both strategies on 
organ dysfunction, regional and microcirculatory flow, 
and tissue hypoxia surrogates.
Materials and methods
Study design
This was a prospective randomized controlled trial con-
ducted at the intensive care units (ICU) of two teaching 
hospitals, Hospital Clínico UC CHRISTUS and Hospital 
Barros Luco-Trudeau of Santiago, Chile. The study was 
approved by the Institutional Review Board of both cent-
ers. A signed informed consent was asked to the next of 
kin of all eligible patients and confirmed by the patients 
when feasible.
Patient selection and randomization
Consecutive adult patients (≥ 18 years) with septic shock 
as defined by a serum lactate > 2 mmol/liter and require-
ments of norepinephrine (NE) to maintain a mean arte-
rial pressure (MAP) ≥ 65  mmHg after an intravenous 
fluid load of at least 20 ml/kg over 60 min [16], and with 
a demonstrated fluid-responsiveness state [17] were con-
sidered as eligible. Patients had to be recruited within a 
period of 24 h after septic shock diagnosis. Exclusion cri-
teria were      pregnancy, anticipated surgery or dialytic 
procedure during the first 6  h after potential inclusion, 
active bleeding, Child B or C liver cirrhosis, severe acute 
respiratory distress syndrome, and do-not-resuscitate 
status.
Eligible patients were randomly allocated to CRT-tar-
geted (CRT-T) or lactate-targeted (LAC-T) fluid resus-
citation arms. A randomization sequence by permuted 
blocks of eight with an allocation of 1:1 was generated by 
a computer program. Allocation concealment was main-
tained by means of central randomization.
Study interventions
The intervention period was of 6  h. Before starting the 
study, all centers were trained to assess CRT with a stand-
ardized technique. Briefly, CRT was measured by apply-
ing firm pressure to the ventral surface of the right index 
finger distal phalanx with a glass microscope slide. The 
pressure was increased until the skin was blank and then 
maintained for 10  s. The time for return of pre-existent 
skin color was registered with a chronometer, and a CRT 
higher than 3 s was defined as abnormal [13].
The perfusion target for CRT-T was a normal CRT 
(≤ 3  s). The perfusion target for LAC-T was an arterial 
lactate ≤ 2  mmol/l or a decrease > 20% every 2  h. CRT 
Clinical Trials: ClinicalTrials.gov Identifier: NCT03762005 (Retrospectively registered on December 3rd 2018)
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was assessed every 30 min and lactate every 2 h during 
the intervention period, after which the treatment was 
liberalized for attending physicians.
Fluid responsiveness was assessed with different tech-
niques according to usual practice and clinical context. 
Cut-offs to consider a patient as fluid responsive for each 
technique are shown in Additional file 1 [18].
The single intervention of the study was the adminis-
tration of repeated fluid boluses. The single interven-
tion of the study was the administration of repeated fluid 
boluses. Fluids (500 ml of Ringer’s lactate administered in 
30-min intervals) were repeated until the perfusion target 
was achieved, or fluid responsiveness became negative, 
or a safety limit of an increase in central venous pressure 
(CVP) ≥ 5 mmHg after a fluid bolus was reached [19].
When the perfusion target could not be achieved with 
fluids, other resuscitation steps such as addition or mod-
ulation of vasoactive agents, or potential rescue thera-
pies were decided by attending physicians. Besides sepsis 
source aggressive management, all patients were treated 
as recommended by current guidelines [2].
Measurements and data collection
Clinical and demographic variables were registered at 
baseline (T0). All patients were followed until hospital 
discharge. All data including demographic aspects, sep-
sis sources and management, inflammatory biomarkers, 
severity scores and major outcomes were registered.
For this research protocol, several specific research-
related variables were measured or calculated at baseline, 
2 (T2), 6 (T6) and at 24 h (T24).
Hemodynamic and clinical perfusion variables included 
fHemodynamic and clinical perfusion variables included 
fluid boluses together with total fluid inputs/outputs and 
fluid balances; macrocirculatory variables such as MAP, 
heart rate, CVP, NE dose, macrocirculatory, cardiac out-
put (CO) assessed with non-invasive pulse-contour tech-
nique (PiCCO device, Pulsion Medical Systems, Munich, 
Germany) or a pulmonary artery catheter; c, Pulsion 
Medical Systems, Munich, Germany; perfusion variables 
such as arterial lactate, central venous oxygen satura-
tion  (ScvO2), and central venous-arterial  pCO2 gradient 
(P(cv-a)  CO2); and; and CRT. CRT.
In addition, regional and microcirculatory perfusion-
related variables were assessed. In addition, regional 
and microcirculatory perfusion-related variables were 
assessed. Sublingual microcirculation was evaluated 
with the side dark field (SDF) device. At each assess-
ment, at least five 10-20 s  video images were recorded. 
The analysis was performed by eye by an expert 
researcher following recent recommendations [20]. 
From image analyses, the microcirculatory flow index 
(MFI) was calculated. A MFI ≤ 2.5 was considered as 
abnormal following some previous reports [3, 21]. 
Plasma-disappearance rate of indocyanine green (PDR-
ICG) was determined with a non-invasive transcu-
taneous assessment of ICG clearance  to indirectly 
assess liver blood flow [22]. An ICG finger clip was 
fixed in every patient and then connected to a liver 
function monitor (LiMON; Pulsion Medical Systems, 
Munich, Germany). A dose of 0.25  mg/kg of ICG was 
then injected through a central venous catheter. Nor-
mal range for PDR-ICG is 18% to 25% per min with a 
value < 15%/min considered as abnormal in some previ-
ous studies [22, 23].  
Near infrared spectroscopy (NIRS): Muscle oxygen 
saturation  (StO2) was assessed by a tissue spectrom-
eter (InSpectra Model 325; Hutchinson Tc, Mn, USA). 
A NIRS probe was placed on the skin of the thenar 
eminence.  StO2 < 70% is abnormal [24]. SDF and PDR-
ICG were only performed at the Hospital Clínico UC 
CHRISTUS SDF and PDR-ICG were only performed at 
the Hospital Clínico UC CHRISTUS.
Two hypoxia-related indexes were also assessed: (1) 
Central venous-arterial  pCO2 gradient/arterial-venous 
 O2 content difference ratio (P(cv-a)CO2/Da-vO2): This 
ratio was calculated after taking arterial and central 
venous blood gases. A ratio ≥ 1.4 may be associated to 
anaerobic  CO2 generation [25–27]. (2) Lactate/pyru-
vate (L/P) ratio: Arterial blood samples for pyruvate 
were taken with immediate deproteinization of the 
sample, and processed in our laboratory before 3 h by 
enzymatic fluorometric-assay (Sigma-Aldrich, USA). 
A L/P ratio > 15 suggests tissue hypoxia  in some pre-
vious work [28]. in some previous work Both ratios 
may represent an expression of anaerobic metabolism 
at the cellular level and thus, may be used as hypoxia 
surrogates.
Outcome measures  
The primary outcome was fluid volume administered 
during the 6  h intervention period. Secondary pre-
specified outcomes included fluid balance at 24 h; 24 h 
SOFA score; and previously mentioned regional, micro-
circulatory flow, and tissue hypoxia surrogates.
Sample size calculation
After a thorough literature review, we found only one 
pilot study comparing peripheral perfusion vs. stand-
ard care based resuscitation in septic shock patients 
[10], showing that the former resulted in signifi-
cantly less resuscitation fluids at 6  h (4227 ± 1081  ml 
vs. 6069 ± 1715  ml). In consequence, we considered a 
1600  ml difference in primary outcome between study 
groups to be the critical threshold for hypothesis testing. 
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If there was no difference between standard and experi-
mental treatments, then 46 patients would be required 
(23 patients per arm) to be 90% sure that the lower limit 
of a two-sided confidence interval was above the limit of 
− 1600 mL at an alpha level of 0.05.
Statistical analysis
As variables presented non-normal distribution, non-
parametric tests were used. Descriptive statistics are 
presented as median [interquartile range] or percentage. 
Mann–Whitney U Test, chi-square or Fisher’s exact test 
were used when appropriate. Two-tailed p value < 0.05 
was considered significant. Data were analyzed with 
Minitab v17 (Minitab Inc, State College, PA) and Graph-
pad Prism (Graphpad Softwares, La Joya, CA) softwares.
Results
Patients characteristics
This study was conducted between June 2018 and 
October 2019, where it was stopped before completing 
the programmed sample size of 46 patients. The deci-
sion was made because of nil further recruitment after 
the start of a severe Chilean social outburst in October. 
During the study period, 149 patients were screened for 
potential protocol inclusion. Patient flow and causes for 
exclusion are represented in Fig.  1. Finally, forty-two 
patients were randomized to both study arms.
Baseline demographic, severity scoring, hemody-
namic and perfusion characteristics are shown in 
Table  1. Time from septic shock diagnosis to protocol 
start was similar in both arms (CRT-T, 4 [2–9] h vs. 
LAC-T, 5 [2–6] h; p = 0.9). The most common tests for 
fluid responsiveness assessment were pulse pressure 
variation (CRT-T, 43% vs. LAC-T, 52%; p = 0.8), infe-
rior vena cava variation (CRT-T, 29% vs. LAC-T, 19%; 
p = 0.4), and passive leg raising with velocity–time inte-
gral (CRT-T, 10% vs. LAC-T, 19%; p = 0.6).
Study outcomes
Table 2 shows a comparison between both study groups 
according to 6 h fluid boluses and balances, 24 h SOFA, 
and perfusion targets. No significant difference was 
observed between groups in the primary outcome of 
resuscitation fluid administration at 6  h. In addition, 
there was no difference between CRT-T and LAC-T 
groups in 24  h SOFA score (10 [5–13] vs. 11 [7–13], 
p = 0.8), 28- day mortality (24% vs. 19%, p = 0.8), ICU (6 
[5–14] vs. 10 [4–20] days, p = 0.8) and hospital length 
of stay (17[6–58] vs. 26 [9–53] days, p = 0.9). Con-
cerning specific resuscitation targets at 6  h, a higher 
21 patients for final analysis
0 were lost to 28-day follow-up 
21 patients for final analysis
149 Patients assessed for eligibility during the 
15-months study period
21 Allocated to Capillary Refill Time 
targeted resuscitation
42 underwent randomization
21 Allocated to Lactate targeted 
resuscitation
90 were ineligible
63     Negative fluid responsiveness assessment
13     Undetermined fluid responsiveness status
12      Do-not-resuscitate status
9         More than 24h after meeting septic shock criteria
3         Anticipated surgery or dialysis procedure next 8 hours
3         Child B or C liver cirrhosis
4  were eligible but were not enrolled
2 Lack of consent
2 Logistic problems 
0 were lost to 28-day follow-up 
Fig. 1 Study flow diagram
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proportion of patients in the CRT-T group achieved 
their objective (62 vs. 24, p = 0.03), as shown in Fig. 2.
Multimodal perfusion assessment
When assessing regional, microcirculatory and hypoxia-
related parameters, no difference between groups was 
observed at the end of the intervention period, as shown 
in Table  3. Additional file  2 shows the number of tests 
performed at each time point in both study groups.
Discussion
CRT-targeted fluid resuscitation was not superior to 
a lactate-targeted one in the primary outcome of fluid 
administration during the 6  h intervention period, 
neither in fluid balances nor organ dysfunction at 24  h. 
However, CRT-targeted resuscitation was associated 
with higher achievement of resuscitation targets during 
the intervention period and exhibited comparable effects 
to LAC-T on regional/microcirculatory flow parameters 
and hypoxia-surrogates.
Our results could be viewed as in contradiction with 
the findings of the ANDROMEDA-SHOCK trial [14], 
particularly in the fluid boluses administered during the 
intervention period. However, the design of the studies 
was markedly different. First, the time-period for recruit-
ment was maximum 4 h, since septic shock diagnosis in 
ANDROMEDA-SHOCK and up to 24  h in the present 
study. Fluid boluses administered in CRT-T were almost 
Table 1 Baseline characteristics of the study population
Data are presented as percentage (absolute number) or median [interquartile range]
CRT Capillary refill time, APACHE II Acute Physiology And Chronic Health Evaluation II, SOFA Sequential organ failure Assessment score, MV Mechanical ventilation, 
MAP Mean arterial pressure, CVP Central venous pressure, ScvO2 central venous oxygen saturation, Delta pCO2(v-a) Difference between central venous carbon dioxide 
pressure and arterial carbon dioxide pressure, P(cv-a)CO2/Da-vO2 ratio central venous-arterial  pCO2 gradient/ arterial-venous, O2 content difference ratio, L/P ratio 
lactate-piruvate ratio, StO2 Thenar muscle oxygen saturation, PDR-ICG Indocianine greeen plasma disappearance rate,MFI Microcirculatory flow index
a Assessed only at Hospital Clínico UC CHRISTUS
CRT targeted group Lactate targeted group
N° 21 21
Age (years) 51 [45–75] 66 [55–75]
Female 48 (10) 66 (14)
APACHE score 23 [15–30] 23 [14–34]
SOFA score 11 [8–14] 12 [9–14]
Septic Source Abdominal: 62 (13) Abdominal 52: (11)
Other: 14 (3) Other: 10 (2)
Respiratory: 14 (3) Respiratory: 14 (3)
Urinary: 10 (2) Urinary: 24 (5)
Surgical Source 57 (12) 62 (13)
Time to antibiotics (min) 60 [45–120] 60 [30–60]
Fluids Pre‑randomization (ml) 1550[1000–3000] 2500 [1250–3175]
MV at inclusion 95 (21) 81 (17)
MAP (mmHg) 71 [66–77] 69 [61–78]
CVP (mmHg) 8 [5–12] 8 [6–10]
Cardiac Index (l/m/m2) 3.1 [2.2–3.5] 2.8 [1.9–3.9]
Norepinephrine dose (mcg/kg/min) 0.23 [0.14–0.54] 0.29 [0.16–0.4]
Lactate (mmol/L) 3 [2.8–5.5] 4 [3–7.6]
CRT (s) 5 [3–6.5] 5 [3–6.5]
ScvO2 (%) 69 [65–78] 70 [59–79]
Delta  pCO2(v‑a) 8 [4–13] 7 [5–11]
P(cv‑a)CO2/Da‑vO2 ratio 2 [1–2.5] 1.3 [1.1–2.8]
L/P ratio 8.1 [4–13.9] 9 [4.7–14]
StO2 (%) 78 [66–82] 78 [70–83]
PDR‑ICGa (%) 18 [10–21.8] 12 [10–15.4]
MFIa 1.75 [1–2.5] 2.6 [2.5–3]
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a half of those in LAC-T, and although this difference is 
not significant, it may suggest that the benefits of CRT-
guided resuscitation may extend for longer periods than 
the limits imposed by ANDROMEDA-SHOCK. Second, 
in the present study only fluid-responsive patients were 
included, and in addition it included fluid administra-
tion as the single intervention. Despite these differences 
in design, LAC-T, the challenged gold-standard, was not 
superior in any of the studied variables, and patients in 
CRT-T achieved their goal in a higher proportion of cases 
during the intervention period.
Table 2 Fluid administration, balance, perfusion targets and  vasopressor dosage in  both  randomization arms 
during the study period
Data are presented as median [interquartile range]
CRT Capillary refill time, NE norepinephrine
CRT targeted group Lactate targeted group p-value
Fluid Bolus 6 h (ml) 875 [375–2625] 1500 [1000–2000] 0.3
Fluid Balance 6 h (ml) 982 [249–2833] 1580 [740–6587] 0.2
Fluid Balance 24 h (ml) 1710 [614–4172] 2015 [166–5060] 0.85
CRT 6 h (s) 3 [2–5] 3 [2–5] 0.8
CRT 24 h (s) 3 [2–4] 3 [2, 3] 0.9
Lactate 6 h (mmol/L) 2.3 [1.8–4] 3.5 [1.8–7.3] 0.4
Lactate 24 h (mmol/L) 2 [1.3–3.2] 1.9 [1.4—4.3] 0.9
NE dose 6 h (mcg/kg/min 0.33 [0.11–0.46] 0.21 [0.12–0‑35] 0.26
NE dose 24 h (mcg/kg/min) 0.14 [0.04–0.32 0.13 [0.01–0.25] 0.6
Fig. 2 Achievement of perfusion target according to study arm at 2, 
6 and 24 h. CRT: Capillary refill time
Table 3 Multimodal perfusion comparison between both study groups at 6 h
Data are presented as percentage (absolute number) or median [interquartile range]
CRT Capillary refill time, MAP mean arterial pressure, CVP Central venous pressure, ScvO2 central venous oxygen saturation, Delta pCO2(v-a) Difference between central 
venous carbon dioxide pressure and arterial carbon dioxide pressure, P(cv-a)CO2/Da-vO2 ratio central venous-arterial  pCO2 gradient/ arterial-venous  O2 content 
difference ratio, L/P ratio lactate-piruvate ratio, StO2 Thenar muscle saturation, PDR-ICG Indocianine greeen plasma disappearance rate, MFI microcirculatory flow index
a Assessed only at Hospital Clínico UC CHRISTUS
CRT-targeted group Lactate targeted group P
MAP (mmHg) 70 [65–65] 73 [64–81] 0.6
CVP (mmHg) 9 [7–12] 10 [8–13] 0.54
Cardiac Index (l/m/m2) 2.7 [2.2–4] 3.1 [2.5–3.9] 0.4
Norepinephrine dose (mcg/kg/min) 0.33 [0.11–0.46] 0.21 [0.12–0.35] 0.26
Lactate (mmol/L) 2.3 [1.8–4] 3.5 [1.8–7.3] 0.37
CRT (s) 3 [2–5] 3 [2–5] 0.82
ScvO2 (%) 68 [66–76] 73 [61–82] 0.38
Delta  pCO2(v‑a) 5 [4–8] 5 [4–8] 0.89
P(cv‑a)CO2/Da‑vO2 ratio 1.58 [1.1–2] 1.8 [1–2.7] 0.6
L/P ratio 12 [6.1–22.2] 8.7 [4.5–12.4] 0.22
StO2 (%) 75 [70–85] 80 [68–85] 0.6
PDR‑ICGa (%) 15.6 [12–24] 13 [6–14] 0.1
MFIa 2.5 [1.5–3] 3 [2.7–3] 0.09
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A possible explanation of our findings is that since CRT 
exhibits a rapid response to flow increasing maneuvers 
it could be assessed in periods of 30  min thus allowing 
clinicians to stop resuscitation in a timely fashion. In 
contrast, lactate exhibits a relatively slow and biphasic 
recovery kinetics even after successful resuscitation [3], 
thus being associated with the potential risk of fluid over-
load. This fact was behind the working hypothesis of the 
previous ANDROMEDA-SHOCK study [14].
Concerning the impact of both strategies on regional 
and microcirculatory flow, to the best of our knowledge 
this is the first study assessing this issue with a multi-
modal approach. In a previous study, Brunauer et  al. 
found a significant correlation between changes in CRT 
with the pulsatility index of various hepatosplanch-
nic arteries during septic shock resuscitation [29]. This 
is physiologically coherent since both territories are 
affected by the adrenergic response to shock that could 
be reverted at least partially by increments in systemic 
flow. Additionally, another study compared dobutamine 
vs. placebo on regional and microcirculatory flow in 
hyperdynamic septic shock, demonstrating that patients 
who normalized CRT exhibited also normal muscle  O2 
saturation and plasma disappearance rate for indocya-
nine green [21]. Although not powered for secondary 
outcomes, our study suggests that CRT-targeted resus-
citation at least does not deteriorate liver blood flow, 
muscle oxygen saturation, and sublingual microvascular 
flow in comparison to a lactate-targeted one. In fact, it 
appears that both strategies lead to a similar improve-
ment in these variables which adds new information 
concerning the safety of targeting peripheral perfusion 
during septic shock resuscitation.
Another peripheral perfusion assessment method is 
the mottling score [30]. Its prognostic value, pathophysi-
ologic correlates [31, 32], as well as its relationship with 
tissue perfusion has been clearly demonstrated [29]. 
Mottling score may be complementary to CRT for a thor-
ough assessment of peripheral perfusion, but less data 
are available on its kinetics of recovery after fluid resusci-
tation. This is the main reason why CRT was selected as a 
target in ANDROMEDA-SHOCK and the present study.
None of the classic perfusion-related parameters reli-
ably reflect the presence or absence of tissue hypoxia. 
Tissue hypoxia should englobe the idea of an impaired 
critical oxygen delivery, and/or the inability of the mito-
chondria to utilize  O2, leading to an exclusive anaerobic 
metabolism in affected territories [33]. Consequently, 
both  O2 consumption and aerobic  CO2 production are 
decreased and a critical amount of anaerobic  CO2 is 
generated due to massive ATP degradation, with the 
resulting buffering of free  H+ with plasma  HCO3−. Once 
tissue hypoxia is established, the reduction of cell redox 
potential shifts the production of ATP to the anaerobic 
pathways, elevating the L/P ratio [33] and furthermore 
increasing anaerobic  CO2 production. This shift could 
rise the respiratory quotient and consequently the P(cv-
a)CO2/ Da-vO2 ratio [26]. Both indexes could theoreti-
cally be used as surrogates of tissue hypoxia and some 
previous studies showed their relationship with hyperlac-
tatemia and progressive shock [34], although the subject 
is controversial [26]. In our study, we observed no differ-
ences between groups on these hypoxia surrogates, again 
suggesting that targeting normal CRT appears as safe at 
the tissue level as compared with the gold standard lac-
tate-targeted resuscitation.
Our study has several limitations. First, there are inher-
ent technical drawbacks and interpretation issues for 
each of the flow-related variables assessed in the study. 
PDR-ICG depends basically on liver blood flow but also 
on liver metabolic function [22]. Thus, pre-existing or 
acute liver dysfunction precludes a correct interpreta-
tion of results. We excluded patients with advanced 
liver dysfunction but cannot rule-out some degree of 
subclinical dysfunction. In addition, the ICG finger clip 
may loose the signal in the presence of profound periph-
eral vasoconstriction. Muscle  StO2 is flow-sensitive and 
was described in hemorrhagic shock, where it improves 
after successful resuscitation [35].  StO2 decreases rap-
idly after a vascular occlusion test and recovers very fast 
after releasing compression [21, 24]. However, its role 
in hyperdynamic states is uncertain. On the other hand, 
after almost two decades of initial description, sublingual 
microcirculatory assessment has not been moved to rou-
tine clinical practice and is still positioned in the research 
arena [38]. Technical aspects, logistics, costs, and lack of 
agreement between experts on the best way to take and 
analyze images have precluded further development [20]. 
In this study, we simplified analyses considering only 
MFI which is a flow-related parameter and the easiest to 
standardize.
Second, in the case of hypoxia surrogates, the back-
ground literature is scarce and both ratios are not uni-
versally accepted. Additional problems are the technical 
difficulties for assessing pyruvate, and the lack of clear 
cut-offs for abnormality. In the case of P(cv-a)CO2/ 
Da-vO2, the use of central venous instead of mixed 
venous  pCO2, and the use of differences in pressures and 
not  CO2 contents could be criticized [26]. However, the 
decision to use the simplified ratio was for practical rea-
sons and has supportive literature [25, 26].
Third, the small sample size may be a problem in 
physiologically focused studies. Therefore, we consider 
these results only as hypothesis-generating, but the data 
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obtained may aid in bringing insights into the mecha-
nisms behind the positive prognostic value of a normal 
CRT after initial fluid resuscitation. Fourth, CRT assess-
ment might be subjected to inter-observer variability, 
but we used a standardized technique that decreases the 
likelihood of bias. Fifth, the premature stop of the study 
may have introduced bias but an independent statistician 
analyzed the results and concluded that recruitment of 4 
more patients would not have changed the p values of the 
main findings. Finally, we could perform SDF and PDR-
ICG techniques in only one of the two involved centers 
for logistic reasons, but we think that this does not invali-
date our conclusions.
Conclusions
CRT-targeted fluid resuscitation in septic shock was not 
superior to a lactate-targeted one on early fluid admin-
istration or fluid balances. However, it was associated 
with comparable effects on regional and microcircula-
tory flow parameters and hypoxia surrogates. In addition, 
achievement of allocated targets was higher for CRT-
guided resuscitation during the 6 h intervention period. 
These data, although only hypothesis generating, expand 
the results of ANDROMEDA-SHOCK suggesting that 
potential benefits of CRT-targeted resuscitation should 
be tested in future studies beyond the limits of very early 
septic shock.
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